EVI1 and hematopoietic disorders: history and perspectives
about
EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2PRDM16 expression in the developing mouse embryoPotential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.Gene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirus.Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.Overexpression of ecotropic viral integration site-1 is a prognostic factor of lung squamous cell cancerMolecular characterization of the rare translocation t(3;10)(q26;q21) in an acute myeloid leukemia patientHigh DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia.Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defectsDown-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemiaRetroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways.Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors.Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.Molecular pathophysiology of myelodysplastic syndromes.miR-133 regulates Evi1 expression in AML cells as a potential therapeutic targetPharmacogenetics of alkylator-associated acute myeloid leukemia.Reducing the genotoxic potential of retroviral vectors.EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylationMolecular diagnosis of acute myeloid leukemia.-7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia.The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.Enhanced sensitivity to hydrogen peroxide-induced apoptosis in Evi1 transformed Rat1 fibroblasts due to repression of carbonic anhydrase III.Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.Insights into the role of reactive sulfhydryl groups of Carbonic Anhydrase III and VII during oxidative damage.Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny.Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report.An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies.Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia.3q26 chromosomal anomalies in acute myeloid leukemia: First descriptions from India.Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia.Dysregulated EVI1 expression in myeloid malignancies.Acute Myeloid Leukemia
P2860
Q24620267-92C4CB56-FB9F-4582-962E-CB449CB8D1B6Q30470827-AD401963-4863-4DB3-A7AB-2A43AD0D75C0Q33511042-B9B5B662-205F-4F8E-8811-EAC86FBA6B65Q33526661-41903F5C-36EE-4B9E-B51E-57F5D5EF31B1Q33713156-67D554F3-961A-41DC-9FEB-87A6CB11842BQ33758448-C92F78D6-C3E1-45E1-B1BE-4EA0167483B7Q33960024-E8127DEA-0982-4793-825B-8F80F227F056Q34516815-33BD3863-1387-4572-B9D4-7A985F649592Q35107227-B5B38ACF-852E-4FC4-B5D8-3798CDBB829FQ35265855-C7F9E8AE-AFD5-4A49-A4AD-7B6266BBC839Q35642820-385BED98-E1EB-48EF-A04C-96FF4F5071CFQ35750824-08E2C32F-C8BB-4EEA-9493-6DD9D64B2EFCQ35849232-ED608BF3-8CDC-4099-AAA9-E439406F5BE1Q36445968-E82E893B-C7D0-4B38-A8F7-643E649133BAQ36453826-D1F9A289-B08F-461F-BC7F-977466236C07Q36555916-B5D65E1B-CACC-4F9B-8F4E-3B7B12B0FB5CQ36670724-F7809D28-B839-45D6-A7A2-0CB68512599AQ37068625-F1810B2B-7B4F-473B-9A2E-E59CFAD1A2CCQ37809866-B41A7A67-7F30-4F34-AF61-A026F414755EQ38226741-D6F0373B-5855-45EB-A7DC-26A2EA970A49Q38275870-DE9A6B3F-8FC1-4E78-9DE3-FF57D4E78FC3Q38299311-6622E3F4-ECAB-4157-BBA1-B039ABC49CBCQ38345216-8EF47EA9-A29B-4D80-AB39-0DB2C733F7D4Q38347948-75AADDC0-B359-41B6-B8CF-A37CC210EA5DQ38459749-04E25591-1F11-4484-9BC8-E67B9485DAAFQ38987207-DC40D530-9814-488C-9284-61670386BFC2Q39129759-746DF1EC-5597-4FD9-8A61-40B8226D4B21Q39320231-A03A31F5-C1EB-4F5F-8C3A-38BED0E9DA1EQ39332914-DFE74D30-1302-4727-BEB3-1C1FB960B6BFQ40128985-C41476C0-21DF-47C0-8A90-2F09DA21B148Q40162781-927837B9-9524-4DD9-8042-8F35A4F1FCE2Q42380741-BEA08C99-8699-493B-BDEB-F9A7712E4E62Q50079841-D12BB62C-9906-4031-A12E-1CBCEAC87B6FQ51134421-27AB12A7-6762-43CD-89D1-DCBF44B2333DQ53582811-7D6F20AA-953B-46F5-A025-E8F6171E24C4Q58481811-5A5BE544-E076-4F17-B35E-A1DB74A43FF8
P2860
EVI1 and hematopoietic disorders: history and perspectives
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
EVI1 and hematopoietic disorders: history and perspectives
@ast
EVI1 and hematopoietic disorders: history and perspectives
@en
EVI1 and hematopoietic disorders: history and perspectives
@nl
type
label
EVI1 and hematopoietic disorders: history and perspectives
@ast
EVI1 and hematopoietic disorders: history and perspectives
@en
EVI1 and hematopoietic disorders: history and perspectives
@nl
prefLabel
EVI1 and hematopoietic disorders: history and perspectives
@ast
EVI1 and hematopoietic disorders: history and perspectives
@en
EVI1 and hematopoietic disorders: history and perspectives
@nl
P2093
P1433
P1476
EVI1 and hematopoietic disorders: history and perspectives
@en
P2093
Giuseppina Nucifora
Leopoldo Laricchia-Robbio
Vitalyi Senyuk
P356
10.1016/J.GENE.2005.09.020
P407
P577
2006-03-01T00:00:00Z